CTOs on the Move

Base Concept Inc

www.baseconcept.com

 
Base Concept Inc is a Mont-Royal, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Wound Management Technologies

Wound Management Technologies is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shore Memorial Hospital

Shore Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Somers Point, NJ. To find more information about Shore Memorial Hospital, please visit www.shorememorial.org

The Hearing And Speech Agency Of Metropolitan Baltimore Inc

The Hearing And Speech Agency Of Metropolitan Baltimore Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Baltimore, MD. To find more information about The Hearing And Speech Agency Of Metropolitan Baltimore Inc, please visit www.hasa.org

LUMEDX

LUMEDX is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Oakland, CA. To find more information about LUMEDX, please visit www.lumedx.com

Enterin Inc.

Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.